About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

UNKNOWNPhase 3

Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL

Efficacy of Maintenance Therapy With Rituximab After Induction Chemotherapy (R-CHOP vs. R-FC) for Elderly Patients With Mantle Cell Lymphoma Not Suitable for Autologous Stem Cell Transplantation

NCT00209209•European Mantle Cell Lymphoma Network

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Lymphoma, Mantle-Cell

Interventions

Rituximab

Cyclophosphamide

+10 more

Locations

7

Czechia

Locations (7)

General University Hospital, 1St Department of Medicine

Prague, Czechia

Nordic Lymphoma Group

Copenhagen, Denmark

Groupe D´Etudes des Lymphomes De l´Adulte (GELA)

Paris, France

German Low Grade Study Group (Glsg)

Munich, Germany

Ospedale Ferratotto, Divisione Di Ematologia

Catania, Italy

HOVON - Dutch Haemato-Oncology Association (HOVON-Datacenter)

Rotterdam, Netherlands

Key Dates

Start Date

January 14, 2004

Primary Completion Date

December 1, 2018

Completion Date

December 1, 2018

Last Updated

March 7, 2017

Related Studies

Enrolling By Invitation

Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells

NCT04911478

Lymphoma, FollicularLymphoma, Mantle-Cell+4 more

COMPLETEDPhase 2

Rituximab, Bendamustine and Cytarabine Followed by Venetoclax in High Risk Elderly Patients With MCL

NCT03567876

Lymphoma, Mantle-Cell

COMPLETEDPhase 2

A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)

NCT02278796

Lymphoma, Large B-Cell, DiffuseLymphoma, Follicular+1 more

COMPLETEDPhase 4

A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion

NCT03190330

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Mantle-Cell

COMPLETEDPhase 1

Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma

NCT02257242

Lymphoma, Non-HodgkinLymphoma, Follicular+4 more

A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice

NCT03425591

Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Mantle-Cell

View all related studies

Sponsors

Lead Sponsor

European Mantle Cell Lymphoma Network

Collaborators

German Low Grade Lymphoma Study Group
Lymphoma Study Association
HOVON - Dutch Haemato-Oncology Association
Nordic Lymphoma Group

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 7, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions